Walgreens Boots Alliance, Inc.

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
11.5 ^USD	+0.61%		+2.13%	-55.96%

Jul. 10	Walgreens Boots Alliance, Inc. Appoints William H. Shrank to Board of Directors	CI
Jul. 10	Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 a Share, Payable Sept. 12 to Shareholders of Record Aug. 21	MT

Tranche Update on Walgreens Boots Alliance, Inc.'s Equity Buyback Plan announced on June 29, 2017.

January 04, 2018 at 04:15 pm EST

From September 1, 2017 to November 30, 2017, the company has repurchased 30,269,913 shares, representing 2.96% for $2,237.27 million. With this, the company has completed the repurchase of 77,439,635 shares, representing 7.36% for $6,000 million under the buyback announced on June 29, 2017.

Latest news about Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. Appoints William H. Shrank to Board of Directors	Jul. 10	CI
Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 a Share, Payable Sept. 12 to Shareholders of Record Aug. 21	Jul. 10	MT
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024	Jul. 10	CI
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target is $13.70	Jul. 09	MT
Top Decliners	Jul. 03	MT
UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating	Jul. 03	MT
Sector Update: Health Care Stocks Softer Late Afternoon	Jul. 02	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	Jul. 02	MT
Sector Update: Health Care	Jul. 02	MT
Walgreens Facing Persistent Retail, Pharmacy Headwinds, RBC Says	Jul. 02	MT
You can't escape politics	Jul. 02
RBC Cuts Price Target on Walgreens Boots Alliance to $13 From $22, Keeps Sector Perform Rating	Jul. 02	MT
ANALYST RECOMMENDATIONS : Adobe, Nike, Solaredge, Welltower, Spectris...	Jul. 02
Nasdaq Closes at Record High as Markets Evaluate Manufacturing Data	Jul. 01	MT
Nasdaq Closes at Record High as Markets Evaluate Manufacturing Sector Data	Jul. 01	MT
Sector Update: Health Care Stocks Retreat Late Afternoon	Jul. 01	MT
US Equities Markets End Higher Monday as Investors Parse Manufacturing Sector Data	Jul. 01	MT
Sector Update: Health Care	Jul. 01	MT
Equity Markets Rise Intraday as Traders Analyze Manufacturing Sector Data	Jul. 01	MT
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01	MT
Correction: Market Chatter: Walgreens Boots Alliance's Boots Unit Sees Top Executive Step Down	Jul. 01	MT
Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	Jul. 01	MT
BofA Securities Cuts Price Target on Walgreens Boots Alliance to $11 From $12, Maintains Underperform Rating	Jul. 01	MT
Walgreens Boots Alliance Chief Executive to Resign	Jul. 01	MT
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $22 From $35, Maintains Buy Rating	Jul. 01	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Sector

Drug Retailers

Calendar

2024-10-09 - Q4 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending

March 28, 2024 at 03:59 pm EDT

Walgreens Boots Alliance, Inc. first light at the end of the tunnel?

November 27, 2023 at 10:22 am EST

More Strategies

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

11.5 USD

Average target price

14.12 USD

Spread / Average Target

+22.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
WALGREENS BOOTS ALLIANCE, INC.	-55.96%	9.93B
JD HEALTH INTERNATIONAL INC.	-41.82%	9.29B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-21.93%	6.82B
MATSUKIYOCOCOKARA & CO.	-2.08%	6.45B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+92.40%	5.26B
NAHDI MEDICAL COMPANY	-2.77%	4.62B
CLICKS GROUP LIMITED	+5.79%	4.56B
YIFENG PHARMACY CHAIN CO., LTD.	-31.67%	3.81B
REDCARE PHARMACY NV	+4.94%	3.06B
WELCIA HOLDINGS CO., LTD.	-20.90%	2.55B

Other Drug Retailers

Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Tranche Update on Walgreens Boots Alliance, Inc.'s Equity Buyback Plan announced on June 29, 2017.

EPS Revisions